Gene expression is altered in the lateral hypothalamus upon activation of the mu opioid receptor

Annals of the New York Academy of Sciences

Volumn 1129, Issue , 2008, Pages 175-184

  Befort, K ^a,b,c,d   Filliol, D ^a,b,c,d   Darcq, E ^a,b,c,d   Ghate, A ^a,b,c,d   Matifas, A ^a,b,c,d   Lardenois, A ^e,f   Muller, J ^e,g,h   Thibault, C ⁱ   Dembele, D ⁱ   Poch, O ^e   Kieffer, B L ^a,b,c,d  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b INSERM   (France)

^c CNRS   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e Laboratoire de Bioinformatique et de Génomique Intégratives

^f UNIVERSITÉ DE RENNES 1   (France)

^g LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^h EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

ⁱ Institut de Génétique et de Biologie Moléculaire et Cellulaire

Author keywords

Knockout mice; Microarray; Morphine; Signaling; Transcription

Indexed keywords

APELIN; APOLIPOPROTEIN D; AQUAPORIN 4; MORPHINE; MU OPIATE RECEPTOR; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN FUNCTION; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; DRUG DEPENDENCE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; HOMEOSTASIS; KNOCKOUT MOUSE; LATERAL HYPOTHALAMUS; MICROARRAY ANALYSIS; MOUSE; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVE STIMULATION; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REWARD; WILD TYPE; ANIMAL; ARTICLE; C57BL MOUSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HYPOTHALAMUS; MALE; METABOLISM; MOUSE MUTANT; POLYMERASE CHAIN REACTION; REPRODUCIBILITY;

ANIMALIA; MUS;

ANIMALS; GENE EXPRESSION REGULATION; HYPOTHALAMUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHINE; POLYMERASE CHAIN REACTION; RECEPTORS, OPIOID, MU; REPRODUCIBILITY OF RESULTS;

EID: 47249143658     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1417.028     Document Type: Conference Paper

References (65)

1. de Lecea, L. et al. 2006. Addiction and arousal: alternative roles of hypothalamic peptides. J. Neurosci. 26 : 10372 10375.
2. Harris, G.C. & G. Aston-Jones. 2006. Arousal and reward: a dichotomy in orexin function. Trends Neurosci. 29 : 571 577.
3. DiLeone, R.J., D. Georgescu & E.J. Nestler. 2003. Lateral hypothalamic neuropeptides in reward and drug addiction. Life Sci. 73 : 759 768.
4. Harris, G.C. et al. 2007. Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward. Behav. Brain Res. 183 : 43 51.
5. Olson, V.G. et al. 2007. Regulation of morphine reward and feeding by CREB in the lateral hypothalamus. Synapse 61 : 110 113.
6. Kieffer, B.L. & C. Gaveriaux-Ruff. 2002. Exploring the opioid system by gene knockout. Prog. Neurobiol. 66 : 285 306.
7. Mansour, A. et al. 1995. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18 : 22 29.
8. Contet, C., B.L. Kieffer & K. Befort. 2004. Mu opioid receptor: a gateway to drug addiction. Curr. Op. Neurobiol. 14 : 1 9.
9. Matthes, H.W.D. et al. 1996. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid receptor gene. Nature 383 : 819 823.
10. Becker, A. et al. 2000. Morphine self-administration in mu-opioid receptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol. 361 : 584 589.
11. Ghozland, S. et al. 2002. Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. J. Neurosci. 22 : 1146 1154.
12. Berrendero, F., B.L. Kieffer & R. Maldonado. 2002. Attenuation of nicotine-induced antinociception, rewarding effects and dependence in mu-opioid receptor knockout mice. J. Neurosci. 22 : 10935 10940.
13. Roberts, A.J. et al. 2000. mu-Opioid receptor knockout mice do not self-administer alcohol. J. Pharmacol. Exp. Ther. 293 : 1002 1008.
14. Mathon, D.S. et al. 2005. Increased gabaergic input to ventral tegmental area dopaminergic neurons associated with decreased cocaine reinforcement in mu-opioid receptor knockout mice. Neuroscience 130 : 359 367.
15. Moles, A., B.L. Kieffer & F.R. D'Amato. 2004. Deficit in attachment behavior in mice lacking the mu-opioid receptor gene. Science 304 : 1983 1986.
16. Koob, G.F. & M. Le Moal. 1997. Drug abuse: hedonic homeostatic dysregulation. Science 278 : 52 58.
17. Ahmed, S.H. et al. 2005. Gene expression evidence for remodeling of lateral hypothalamic circuitry in cocaine addiction. Proc. Natl. Acad. Sci. USA 102 : 11533 11538.
18. Boutrel, B. et al. 2005. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc. Natl. Acad. Sci. USA 102 : 19168 19173.
19. Paxinos, G. & K. Franklin. 2000. The mouse brain in stereotaxic coordinates. San Diego.
20. Eisen, M.B. et al. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95 : 14863 14868.
21. de Hoon, M.J. et al. 2004. Open source clustering software. Bioinformatics 20 : 1453 1454.
22. Altschul, S.F. et al. 1990. Basic local alignment search tool. J. Mol. Biol. 215 : 403 410.
23. Benson, D.A. et al. 2007. GenBank. Nucleic Acids Res. 35 : D21 25.
24. Pruitt, K.D., T. Tatusova & D.R. Maglott. 2007. NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 35 : D61 65.
25. Wheeler, D.L. et al. 2007. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 35 : D5 12.
26. Uniprot, C. 2007. The Universal Protein Resource (UniProt). Nucleic Acids Res. 35 : D193 197.
27. Lander, E.S. et al. 2001. Initial sequencing and analysis of the human genome. Nature 409 : 860 921.
28. Livak, K.J. & T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 : 402 408.
29. Abou-Sleymane, G. et al. 2006. Polyglutamine expansion causes neurodegeneration by altering the neuronal differentiation program. Hum. Mol. Genet. 15 : 691 703.
30. Schulteis, G. et al. 1995. Decreased brain reward produced by ethanol withdrawal. Proc. Natl. Acad. Sci. USA 92 : 5880 5884.
31. Epping-Jordan, M.P. et al. 1998. Dramatic decreases in brain reward function during nicotine withdrawal. Nature 393 : 76 79.
32. Paterson, N.E., C. Myers & A. Markou. 2000. Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats. Psychopharmacology (Berl) 152 : 440 446.
33. Venero, J.L. et al. 1999. Detailed localization of aquaporin-4 messenger RNA in the CNS: preferential expression in periventricular organs. Neuroscience 94 : 239 250.
34. Zeng, X.N. et al. 2007. Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes. Mol. Cell Neurosci. 34 : 34 39.
35. McClung, C.A., E.J. Nestler & V. Zachariou. 2005. Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area. J. Neurosci. 25 : 6005 6015.
36. Befort, K. et al. under revision. Mu-opioid receptor activation induces transcriptional plasticity in the central extended amygdala.
37. Li, Z. et al. 2006. Aquaporin-4 knockout regulated cocaine-induced behavior and neurochemical changes in mice. Neurosci. Lett. 403 : 294 298.
38. Thomas, E.A., D.L. Copolov & J.G. Sutcliffe. 2003. From pharmacotherapy to pathophysiology: emerging mechanisms of apolipoprotein D in psychiatric disorders. Curr. Mol. Med. 3 : 408 418.
39. Thomas, E.A. et al. 2001. Clozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy. J. Neurochem. 76 : 789 796.
40. Del Signore, A. et al. 2006. Gene expression pathways induced by axotomy and decentralization of rat superior cervical ganglion neurons. Eur J. Neurosci. 23 : 65 74.
41. Flatscher-Bader, T. & P.A. Wilce. 2006. Chronic smoking and alcoholism change expression of selective genes in the human prefrontal cortex. Alcohol Clin. Exp. Res. 30 : 908 915.
42. Qu, W.M. et al. 2006. Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep. Proc. Natl. Acad. Sci. USA 103 : 17949 17954.
43. Nishida, Y., M. Yoshioka & J. St-Amand. 2006. Regulation of hypothalamic gene expression by glucocorticoid: implications for energy homeostasis. Physiol. Genomics 25 : 96 104.
44. Mong, J.A. et al. 2003. Estradiol differentially regulates lipocalin-type prostaglandin D synthase transcript levels in the rodent brain: Evidence from high-density oligonucleotide arrays and in situ hybridization. Proc. Natl. Acad. Sci. USA 100 : 318 323.
45. Ishizaka, M. et al. 2001. Inflammatory stimuli increase prostaglandin D synthase levels in cerebrospinal fluid of rats. Neuroreport 12 : 1161 1165.
46. Liang, X. et al. 2005. Prostaglandin D2 mediates neuronal protection via the DP1 receptor. J. Neurochem. 92 : 477 486.
47. Korostynski, M. et al. 2007. Morphine effects on striatal transcriptome in mice. Genome Biol. 8 : R128.
48. Ammon, S. et al. 2003. Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal. Brain Res. Mol. Brain Res. 112 : 113 125.
49. Kerns, R.T. et al. 2005. Ethanol-responsive brain region expression networks: implications for behavioral responses to acute ethanol in DBA/2J versus C57BL/6J mice. J. Neurosci. 25 : 2255 2266.
50. Treadwell, J.A. & S.M. Singh. 2004. Microarray analysis of mouse brain gene expression following acute ethanol treatment. Neurochem. Res. 29 : 357 369.
51. Gonzalez-Nicolini, V. & J.F. McGinty. 2002. Gene expression profile from the striatum of amphetamine-treated rats: a cDNA array and in situ hybridization histochemical study. Brain Res. Gene Exp. Patterns 1 : 193 198.
52. Nonogaki, K., K. Ohashi-Nozue & Y. Oka. 2006. Induction of hypothalamic serum- and glucocorticoid-induced protein kinase-1 gene expression and its relation to plasma des-acyl ghrelin in energy homeostasis in mice. Biochem. Biophys. Res. Commun. 344 : 696 699.
53. Levitt, P. et al. 2006. Making the case for a candidate vulnerability gene in schizophrenia: Convergent evidence for regulator of G-protein signaling 4 (RGS4). Biol. Psychiatry 60 : 534 537.
54. Hooks, S.B., K. Martemyanov & V. Zachariou. 2008. A role of RGS proteins in drug addiction. Biochem. Pharmacol. 75 : 76 84.
55. Gold, S.J. et al. 1997. Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J. Neurosci. 17 : 8024 8037.
56. Zhang, D. et al. 2005. Repeated cocaine administration induces gene expression changes through the dopamine D1 receptors. Neuropsychopharmacology 30 : 1443 1454.
57. Tatemoto, K. et al. 1998. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem. Biophys. Res. Commun. 251 : 471 476.
58. O'Dowd, B.F. et al. 1993. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136 : 355 360.
59. Reaux, A. et al. 2002. Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience 113 : 653 662.
60. De Mota, N. et al. 2004. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc. Natl. Acad. Sci. USA 101 : 10464 10469.
61. Kleinz, M.J. & A.P. Davenport. 2005. Emerging roles of apelin in biology and medicine. Pharmacol. Ther. 107 : 198 211.
62. O'Donnell, L.A. et al. 2007. Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury. J. Neurochem. 102 : 1905 1917.
63. O'Carroll, A.M., A.L. Don & S.J. Lolait. 2003. APJ receptor mRNA expression in the rat hypothalamic paraventricular nucleus: regulation by stress and glucocorticoids. J. Neuroendocrinol. 15 : 1095 1101.
64. Jaszberenyi, M., E. Bujdoso & G. Telegdy. 2004. Behavioral, neuroendocrine and thermoregulatory actions of apelin-13. Neuroscience 129 : 811 816.
65. Mollereau, C., M. Roumy & J.M. Zajac. 2005. Opioid-modulating peptides: mechanisms of action. Curr. Top. Med. Chem. 5 : 341 355.